This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Nafakhi H, Al-Mosawi AA, Mudhafar MM (2019) Pericardial fat versus BMI in the assessment of coronary atherosclerotic burden in patients with diabetes mellitus. Acta Diabetol. https://doi.org/10.1007/s00592-019-01465-9
Zsóri G, Illés D, Ivány E et al (2019) In new-onset diabetes mellitus, metformin reduces fat accumulation in the liver, but not in the pancreas or pericardium. Metab Syndr Relat Disord 17(5):289–295
Jonker JT, Lamb HJ, van der Meer RW et al (2010) Pioglitazone compared with metformin increases pericardial fat volume in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95(1):456–460
Hsu JC, Wang CY, Su MM, Lin LY, Yang WS (2019) Effect of empagliflozin on cardiac function, adiposity, and diffuse fibrosis in patients with type 2 diabetes mellitus. Sci Rep 9(1):1534
Christensen RH, von Scholten BJ, Hansen CS et al (2019) Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes. Cardiovasc Diabetol 18(1):114
Conflict of interest
The authors declare that they have no conflict of interest.
Not required for this type of manuscript.
Human and animal rights
This manuscript does not contain any human or animal studies performed by any of the authors.
For this type of study, formal consent was not necessary.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Managed by Massimo Porta.
About this article
Cite this article
Patoulias, D., Papadopoulos, C. & Doumas, M. Pericardial fat in type 2 diabetes: not just a biomarker, but a promising treatment target?. Acta Diabetol 57, 905–906 (2020). https://doi.org/10.1007/s00592-020-01478-9